Literature DB >> 8131084

Synaptophysin and chromogranin A immunoreactivities of Lewy bodies in Parkinson's disease brains.

M Nishimura1, H Tomimoto, T Suenaga, S Nakamura, Y Namba, K Ikeda, I Akiguchi, J Kimura.   

Abstract

Lewy bodies commonly observed in brains with Parkinson's disease (PD) histochemically contain both protein and lipid as chemical components. Ultrastructurally, they are composed of filamentous, vesicular and granular structures. We investigated PD brains with light and electron microscopic immunohistochemistry using antibodies against two marker proteins for neuronal secretory vesicles, synaptophysin and chromogranin A. Both antibodies immunolabeled the peripheral zones and occasionally central cores of Lewy bodies of the classical and intraneuritic types. In addition, the diffuse immunolabeling was observed in Lewy bodies of the cortical type. Furthermore, the ultrastructural immuno-decoration was found mainly in the vesicular structures, and also in the filamentous and granular structures of Lewy bodies. Immuno-blot analysis of each antibody showed no difference between PD and normal control brains. The present observations suggest that vesicular profiles of Lewy bodies represent presynaptic and dense core secretory vesicles, and therefore that the lipid elements of Lewy bodies are derived from membrane lipids of these vesicles.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8131084     DOI: 10.1016/0006-8993(94)91940-2

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  21 in total

Review 1.  The Lewy body in Parkinson's disease and related neurodegenerative disorders.

Authors:  Koichi Wakabayashi; Kunikazu Tanji; Saori Odagiri; Yasuo Miki; Fumiaki Mori; Hitoshi Takahashi
Journal:  Mol Neurobiol       Date:  2012-05-24       Impact factor: 5.590

Review 2.  Chromogranins A and B as regulators of vesicle cargo and exocytosis.

Authors:  José D Machado; Jésica Díaz-Vera; Natalia Domínguez; Carmen M Alvarez; Marta R Pardo; Ricardo Borges
Journal:  Cell Mol Neurobiol       Date:  2010-11-03       Impact factor: 5.046

Review 3.  Antibacterial peptides are present in chromaffin cell secretory granules.

Authors:  M H Metz-Boutigue; Y Goumon; K Lugardon; J M Strub; D Aunis
Journal:  Cell Mol Neurobiol       Date:  1998-04       Impact factor: 5.046

Review 4.  Parkinson's disease: proteinopathy or lipidopathy?

Authors:  Saranna Fanning; Dennis Selkoe; Ulf Dettmer
Journal:  NPJ Parkinsons Dis       Date:  2020-01-03

5.  Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disorders.

Authors:  A Takeda; M Mallory; M Sundsmo; W Honer; L Hansen; E Masliah
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

6.  Loss of native α-synuclein multimerization by strategically mutating its amphipathic helix causes abnormal vesicle interactions in neuronal cells.

Authors:  Ulf Dettmer; Nagendran Ramalingam; Victoria E von Saucken; Tae-Eun Kim; Andrew J Newman; Elizabeth Terry-Kantor; Silke Nuber; Maria Ericsson; Saranna Fanning; Tim Bartels; Susan Lindquist; Oren A Levy; Dennis Selkoe
Journal:  Hum Mol Genet       Date:  2017-09-15       Impact factor: 6.150

7.  Chromogranin A detection in saliva of type 2 diabetes patients.

Authors:  Martine Soell; Ahmed Feki; Matthias Hannig; Hidehiko Sano; Michel Pinget; Denis Selimovic
Journal:  Bosn J Basic Med Sci       Date:  2010-02       Impact factor: 3.363

8.  Intraneuronal dopamine-quinone synthesis: a review.

Authors:  D Sulzer; L Zecca
Journal:  Neurotox Res       Date:  2000-02       Impact factor: 3.911

9.  Cerebrospinal fluid levels of chromogranin A in the treatment-naïve early stage Parkinson's disease: a pilot study.

Authors:  Michaela Kaiserová; Hana Přikrylová Vranová; David Stejskal; Kateřina Menšíková; Petr Kaňovský
Journal:  J Neural Transm (Vienna)       Date:  2013-04-16       Impact factor: 3.575

10.  Secretoneurin promotes neuroprotection and neuronal plasticity via the Jak2/Stat3 pathway in murine models of stroke.

Authors:  Woei-Cherng Shyu; Shinn-Zong Lin; Ming-Fu Chiang; Der-Cherng Chen; Ching-Yuan Su; Hsiao-Jung Wang; Ren-Shyan Liu; Chang-Hai Tsai; Hung Li
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.